Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Items 601–630 of 630
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Ortego, A. (2023) · Materials research foundations · doi:10.21741/9781644902639-9 · Cited by 1
Unveiling an Antibiofilm Marvel to Combat Antibiotics Resistance
-, S. K. M., -, S. K. G., -, R. P. Y., -, S. S., & Rajat (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i06.8821
Nguyen, A. H., Axell‐House, D. B., Miller, W. R., & Arias, C. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00046-0
Epithelial Barrier Dysfunction in Disease
Pardo-Pastor, C., López-Posadas, R., & Zapater, E. O. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4669-7
BENEFITS AND RISKS OF USING ENTEROCOCCUS SPECIES IN FOOD OR AS PROBIOTICS
Yordanova, R., Hristova, P., & Platikanova, M. (2024) · Journal of IMAB - Annual Proceeding (Scientific Papers) · doi:10.5272/jimab.2024302.5569 · Cited by 1
Gut-Brain Axis: Development of Cancer
Mohammadi, T., & Mohebalizadeh, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_373-1
NOVEL PERSPECTIVES ON THE CONTRIBUTORS TO INFLAMMATORY BOWEL DISEASE DEVELOPMENT
Kiani, F. A., FAROOQ, A., Javid, M., SALEEM, M., Ahmed, Z., RASOOL, F., KHAN, S., NAWAZ, M., AZEEM, M., & MEHMOOD, K. (2024) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2024i1.1362
Cancer and microbiome-targeted therapies
Meena, A. S., Singh, P., & Shukla, P. K. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.006 · Cited by 5
Knotek, A. A. U., & Kristich, C. J. (2025) · Journal of Bacteriology · doi:10.1128/jb.00099-25
“…which depletes the gut of susceptible microbes, is a known risk factor for the establishment of enterococcal infections (5, 6) because intrinsically cephalosporin-resistant E. faecalis can proliferate within the gastrointestinal tract and disseminate to other sites to establish infection (7–10).”
Gut-Brain Axis: Development of Cancer
Mohammadi, T., & Mohebalizadeh, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_373
Bayhan, G. İ., Coşkun, Z. N., Bayraktar, P., Demir, A., Demir, B. N., Keser, M. K., Yüksek, S. K., Özen, S., Parlakay, A. Ö., Dinç, B., et al. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02171-0
“This could be due to the negative impact of vancomycin on the microbiota [19].”
Additional file 1 of Microbial signature in IgE-mediated food allergies
Goldberg, M. R., Mor, H., Neriya, D. M., Magzal, F., Muller, E., Appel, M. Y., Nachshon, L., Borenstein, E., Tamir, S., Louzoun, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13151880
Current Management of Serious Infections due to Vancomycin-resistant Enterococci
Gomez-Villegas, S. I., Wh, M., & Arias, C. A. (2026) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.12.004
张, 淇. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1631065
Yu, L., Lin, G., Lin, Y., Fang, Q., Yang, S., Zhang, X., Liu, J., Chen, G., & Luo, C. Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151682 · Cited by 1
消化管酵素トリプシンの分解に関与するヒト腸内常在細菌の同定および分解メカニズムの解明に関する研究
Watanabe, E. (2019) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002002448
Fischer, N. (2014) · theses.fr (ABES) · doi:10.70675/7ecf88e2z7851z4354zb134z317e666a94cb · Cited by 1
Insights into the interaction of Enterococcus faecalis with host cells
Nunez, N. (2017) · theses.fr (ABES) · doi:10.70675/8636c8afzcac0z4f40za0ffz5a6d9da835c0
“The prolonged use of broad-spectrum ampicillin also showed that high risk patients presented VRE production of RegIII is exploited by Enterococcus that, despite initial low abundance in the gut, outgrows and becomes a predominant colonizer (Brandl et al., 2008).”
BackgroundInfluentialCherrak, Y. (2020) · theses.fr (ABES) · doi:10.70675/50fe6f7bz2852z46e8z8c69z34c04bfce736
Rôle de REG3A dans la maladie métabolique du foie d'origine nutritionnelle
Nguyen, T.-S. (2024) · theses.fr (ABES) · doi:10.70675/2c0ffdcfz96ccz43b0z8e03zb358f83e528d
An Ultrasensitive and Novel Gene Sensor to Monitor Gut MicrobiomePreprint
Rana, M., Stewart, M., Rodrigues, M., Toprak, E., Koh, A. Y., & Argun, A. A. (2026) · medRxiv · doi:10.64898/2026.04.30.26352170
Vasil, E., Papanicolas, L. E., Miller, S. J., Shoubridge, A. P., Taylor, S., & Rogers, G. B. (2026) · Journal of Infection · doi:10.1016/j.jinf.2026.106774
Chuang, Y., Collman, R. G., Ruan, S., Chien, Y., Huang, Y.-J., Hsu, C.-C., Jann-Tay, W., Zou, H.-B., & Chang, S. (2026) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-026-00871-6
“Additionally, antimicrobial disruption of the gut microbiome may downregulate RegIIIγ, a lectin that kills Gram-positive bacteria including VRE, thus facilitating VRE colonization [7].”
Gut microbiota links to infection in liver transplantation
Hinkle, C., Friedman, D., & Lehmann, C. J. (2026) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001304
Xu, W., Li, F., Zhou, Y., Song, C., Li, Y., & Liu, Z. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05165-1
“…of innate immunity, the intestinal barrier is stimulated by lipopolysaccharide (LPS), which activates the Toll-like receptor (TLR) 4–MYD88 signaling pathway, leading to the production of the antimicrobial peptide RegIIIγ to resist pathogen colo - nization (Brandl et al. 2008, Gibson et al. 2008).”
Wheeler, M., & Bakkeren, E. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001856
“Typhimurium , E. faecalis and Listeria monocytogenes [133–135], but are depleted in response to antibiotic therapy [134].”
Hasegawa, M., Koizumi, Y., Das, N. K., Zhang, L., Lyssiotis, C. A., Shah, Y. M., Fukuda, S., Núñez, G., & Inohara, N. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.09.020
BindingDB (2022) · UC San Diego · doi:10.7270/q2fr019p
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.